Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
112,692
Sort by:
Competitor Analysis: Tissue Growth Factors
US$ 960.00
... description The present Competitive Intelligence Report about tissue growth factors provides a competitor evaluation in the field of molecules such as proteins, peptides ... as HGF, VEGF, TGF, NGF, GDF and quite a number of neurotrophic factors are under development. Apart from proteins as the classical drugs ...
December 2009
57 pages
Competitor Analysis: FGF-R Agonists and Antagonists
US$ 216.00
Product description The present Competitive Intelligence Report about TGF-R agonists and antagonists provides a competitor evaluation in the field of transforming growth factor receptor (TGF-R) or TG...
November 2009
20 pages
The Roche Intelligence Dossier
US$ 295.00
As the fourth largest pharmaceutical company in the world, with annual revenues of $43.9 billion, some of the most instantly recognisable drugs marketed and the kind of pipeline smaller companies only...
November 2009
48 pages
The GSK Intelligence Dossier
US$ 295.00
After two anemic years, GSK is ready to breathe new life.Despite intense competition from generics in the US, the company has finally reported a healthy growth in the third quarter of 2009.Now, eager...
November 2009
53 pages
The Novartis Intelligence Dossier
US$ 295.00
International censure over Novartis’ grave delays in supplying the H1N1 vaccine.Renewed criticism by an institutional investor for CEO Daniel Vasella’s substantial pay package and considerable power.A...
November 2009
55 pages
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
US$ 5,650.00
... and forecast This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the ... positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders. - Comprehensive market analysis for the following sectors: ...
November 2009
126 pages
Competitor Analysis: FGF-R Agonists and Antagonists
US$ 360.00
Product description The present Competitive Intelligence Report about FGF-R agonists and antagonists provides a competitor evaluation in the field of fibroblast growth factor receptor (FGF-R) or PDGF targeting molecules for wound healing, cardiac tissue repair, bone formation or treatment of cancer as of ...
November 2009
37 pages
Competitor Analysis: Proteasome Inhibitors
US$ 120.00
... R&D Stage and additional comments with a hyperlink leading to the source of information. Index Velcade Pipeline Proteasome Inhibitors Corporate Proteasome Inhibitor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise ...
November 2009
14 pages
Competitor Analysis: CXCR and CXCL Agonists and Antagonists
US$ 360.00
... The present Competitive Intelligence Report about CXCR agonists and CXCR/CXCL antagonists provides a competitor evaluation in the field of chemokine receptor ... approved and marketed drug is plerixafor (AMD3100), a small molecule inhibitor of the CXCR-4/SDF-1 axis, used for stem cell mobilization. CXCR1 and ...
November 2009
30 pages
Conference Intelligence Dossier: EASD Annual Meeting 2009
US$ 995.00
The numbers are staggering: More than 200 million people around the world now suffer from diabetes and its major complications. According to the World Health Organization, that figure is expected to s...
October 2009
90 pages
The Pfizer Intelligence Dossier
US$ 295.00
In boardrooms, around water coolers and behind closed office doors, decision-makers in the pharmaceutical industry are asking questions: What’s happening with Pfizer? What developments have occurred i...
October 2009
60 pages
European Markets for Dental Dental Growth Factors 2009
US$ 4,495.00
The European markets for dental growth factors include the markets for emdogain, in addition to the markets for potential dental growth factors such as GEM-21S and INFUSE and Platelet Rich Plasma (PRP)
September 2009
69 pages
Autoimmune Treatment (2009 - 2014)
US$ 5,650.00
... . The global market for autoimmune disease treatments is estimated to be at $37.84 billion in 2009, and is growing at a CAGR of 12.7% from 2009 to 2014 to reach an estimated $68.81 billion in 2014. The effects of the global ... 2009 to 2014. Scope of the Report The report provides market overviews and forecasts as well as market drivers and restraints for the global autoimmune treatment ...
September 2009
159 pages
Asia Medical Tourism Analysis (2008 - 2013)
US$ 1,000.00
Asia medical tourism industry has been growing with a double digit CAGR and expected to reach US$ 8.5 Billion by 2013. Thailand and India vie with each other for the medical tourism crown. Thailand’s...
September 2009
73 pages
BMS & Medarex: a Valuable Partnership?
US$ 295.00
A positive move, but not one which deals with Bristol-Myers Squibb’s upcoming patent expiry problems On July 22, 2009, Bristol-Myers Squibb announced that it would acquire – at a considerable premium...
August 2009
ASCO 2009: Significant Developments in Context
US$ 995.00
The recent ASCO meeting was attended by around 30,000 cancer researchers and physicians and over 4,000 abstracts covering a wide range of clinical trial results and related topics were presented. How...
July 2009
175 pages
Johnson & Johnson: Positioning for Market Leadership?
US$ 295.00
How does the world's 7th largest pharma company plan to grow its pharmaceutical revenues? For competitors and investors alike this is a key question, and one that must be considered in the light of t...
July 2009
Research Report on Chinese Avermectin Industry, 2009-2010
US$ 1,890.00
Avermectin is a new antibiotic used for agriculture and animals. It has high bioactivity on mites and pests of many crops. It is also an ideal antibiotic insecticide and acaricide. It is broad-spectru...
July 2009
60 pages
European Markets for Dental Prosthetics and CAD/CAM 2009 (16 Countries)
US$ 11,495.00
In 2008, the European market for dental prosthetics (crowns, bridges, and dentures) was valued at nearly €8.3 billion. The European market includes Austria, ... Kingdom. The global economic downturn in 2008 – 2009 is expected to slow the market growth rate however; the aging population will continue to drive the ...
July 2009
650 pages
Research report on home medical device market
US$ 400.00
In recent ten years, China’s community hospitals and basic hospitals have been booming, which means China is experiencing the second stage that developed countries have already experienced, at the sam...
July 2009
10 pages
Nanomedicine: Market Research Report
US$ 3,950.00
This report analyzes the Global Market for Nanomedicine in Millions of US$ by the following Application Areas: Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, ... Nanotechnologies, Inc., Starpharma Pty.Ltd., and Wyeth Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary ...
July 2009
698 pages
U.S. Markets for Dental Bone Graft Substitutes 2009
US$ 7,495.00
In 2008, the combined U.S. market for dental bone graft substitutes and other biomaterials was valued at just under $200 million. This market includes bone graft substitutes, tissue engineering products, and dental membranes. The market is expected to ...
June 2009
129 pages
Analysis Report of China's Multivitamin Market
US$ 350.00
Multivitamin is a vitamin product mixed of more than two kinds of single vitamins in due proportion. On a world wide scale, multivitamin is a huge market worth more than tens of billions of dollars, a...
June 2009
7 pages
Research report of China’s private hospitals
US$ 350.00
Since 1980s, private hospitals began to appear in the medical industry, after many years of development, they have become an important supplementary force of the national medical and health services,...
June 2009
7 pages
Wound Care Markets, 4th. Edition, Vol. II: Burns
US$ 2,995.00
Wound care is a constantly changing market. New wound care products and devices are entering the market with quickly to treat the most painful and critical of injuries, all striving for the best clini...
April 2009
200 pages
Report of Traditional Chinese Medicine Industry under, 2009
US$ 1,392.00
The traditional Chinese medicine is Chinese traditional medical science. The traditional Chinese medicines mainly conclude traditional Chinese medical materials, traditional Chinese medicine pills and...
April 2009
60 pages
Telemedicine: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Telemedicine in US$ Millions. The report analyzes the market for telemedicine by the following segments: Technology (Hardware/Equipment, Software, & Telecommunications & Network), and Services.The report provides separate comprehensive analytics for US, Canada, ...
April 2009
788 pages
Liquid Chromatography Markets (LC, HPLC and UHPLC)
US$ 3,500.00
The liquid chromatography (LC) market has been relatively mature for quite a while, with a slow evolution of products and applications over the last few decades. High performance liquid chromatography...
March 2009
178 pages
Wound Care Markets, 4th. Edition, Vol. I: Skin Ulcers
US$ 2,995.00
Wound care is a constantly changing market. The trend toward cost-effective skin ulcer treatment remains embedded in management programs that emphasize prevention and early intervention. New wound car...
March 2009
150 pages
U.S. Market for Chronic Venous Insufficiency Treatment 2009
US$ 7,495.00
CVI is the underlying cause for a majority of lower leg venous ulcers. Compression treatment with Unna boots is the most widely used treatment for venous ulcers, with over 50% of patients using them. Both the number of patients with CVI and the number of patients diagnosed is expected to increase over the ...
March 2009
53 pages
U.S. Market for Psoriasis Cream and Medication 2009
US$ 7,495.00
The psoriasis treatment market includes all over-the-counter and prescription pharmaceutical products used to treat psoriasis. This includes topical tar, salicylic acid, corticosteroids, combination corticosteroids, vitamin D analogs, anthralin, retinoids, methotrexate, cyclosporine, and biologic treatments. ...
March 2009
96 pages
Patient Monitoring Industry: Focus on Capnography Market
US$ 750.00
The capnography monitoring devices market, a part of the patient monitoring industry, is characterized as a large under-penetrated market globally. Worldwide, the ... The report analyzes the various segments of the capnography monitoring devices industry and assesses opportunities available for the players. The ...
March 2009
34 pages
Research Report on Chinese Medical Industry, 2009
US$ 1,378.80
In China, the medical organizations refer to the organizations received Practice License of Medical Institution, mainly including the specialized diagnostic and curative hospitals, health centers, con...
March 2009
80 pages
Global HIV Market: An Analysis
US$ 700.00
... rates. It also gives an overview of HIV virus and therapies in demand. The report presents overview of global market, HIV in US, UK, Asia and Sub-Saharan ... Africa. It highlights major markets for HIV drugs with overall market value and major ...
February 2009
25 pages
